Optic Neuritis
Optic neuritis is inflammation of the optic nerve causing subacute visual loss, impaired colour vision, a relative afferent pupillary defect and often pain on eye movement; it needs urgent eye assessment and may be the first presentation of multiple sclerosis or antibody-mediated disease.
In a nutshell
Optic neuritis causes subacute visual loss, pain on eye movement, impaired colour vision and an RAPD, usually in one eye. The disc may be normal because the lesion is retrobulbar. It needs urgent ophthalmology and consultant-neurology assessment; MRI informs MS risk but does not diagnose MS alone. Specialist high-dose corticosteroids may speed recovery without improving final vision. Bilateral, severe, recurrent or poorly recovering disease raises concern for NMOSD or MOG-antibody disease.
Classic presentation
A young adult develops painful loss of vision in one eye over several days, with washed-out colours, a central field defect and an RAPD; the optic disc may look normal.
Key points
- Subacute unilateral visual loss with pain on eye movement and red desaturation is the classic pattern.
- The RAPD is elicited with the swinging light test and localises an asymmetric optic-nerve or retinal afferent lesion.
- A normal optic disc does not exclude optic neuritis; retrobulbar disease is common.
- Confirm with urgent ophthalmic assessment and refer confirmed isolated optic neuritis to consultant neurology.
- MRI helps assess optic-nerve inflammation and MS risk, but MRI findings alone do not establish MS.
- Steroids may speed recovery but do not usually change final vision; avoid standard-dose oral prednisolone alone.
- Bilateral, severe, recurrent, painless or poorly recovering disease needs an NMOSD/MOG and alternative-cause work-up.
First-line investigation
Visual acuity, colour vision, pupils/RAPD, fields, motility and fundus assessment urgently, followed by specialist-directed MRI of the brain and orbits.
Management
Assess urgently and exclude dangerous mimics
Confirm the optic-nerve lesion and phenotype
Refer confirmed isolated optic neuritis to neurology
- NICE recommends consultant-neurology assessment after isolated optic neuritis has been confirmed by an ophthalmologist; classify clinically isolated syndrome, MS, NMOSD, MOG-antibody disease or another cause.1
Use specialist high-dose steroid or neuroimmunology pathways
Monitor recovery and future neurological disease
Exam traps
- A normal-looking disc does not rule out optic neuritis.
- The RAPD is a swinging-light finding, not unequal pupil size.
- MRI lesions support diagnostic assessment and risk stratification but do not diagnose MS in isolation.
- Bilateral, painless, very severe, recurrent or progressive disease is atypical and should prompt NMOSD/MOG or structural/infectious investigation.
- Steroids speed visual recovery but do not usually improve the final visual outcome; standard-dose oral prednisolone alone is inappropriate.
- Transient heat- or exercise-related blurring is Uhthoff phenomenon and is not automatically a new relapse.
Illustrations
Key sources
- NICE, Multiple sclerosis in adults: management (NG220 recommendations, last updated 3 June 2026)Updated 3 Jun 2026
- NHS Cornwall and Isles of Scilly, Optic nerve referral guidance (RMS clinical referral guideline, reviewed 30 September 2025)Updated 30 Sept 2025
- Hull University Teaching Hospitals NHS Trust, Optic neuritis (Patient information HEY1422/2023, updated 30 November 2023)Updated 30 Nov 2023
- NHS, Neuromyelitis optica (NHS Health A to Z, last reviewed 20 December 2024)Updated 20 Dec 2024
- NHS Highland, Optic neuritis guideline (Adult therapeutic ophthalmology emergency pathway)
- BNF, Methylprednisolone (BNF drug monograph)
- North West London Pathology, MOG antibody (NHS laboratory test information)
- University Hospitals Birmingham, Multiple sclerosis diagnosis and symptoms (NHS referral pathway, reviewed 4 December 2024)Updated 4 Dec 2024
- NICE CKS, Giant cell arteritis (Clinical Knowledge Summary)
This page is exam revision material, not medical advice, and must not be used for patient care. Always check drug doses against the BNF and current guidance. Full disclaimer.

